ResMed | RMD - مصاريف البيع والإدارة

سعر السهم
228.80
التغيير اليومي
-1.89 -0.82%
شهريا
-0.78%
سنويا
8.18%
Q2 التوقعات
222.62




مصاريف البيع والإدارة تغيير تاريخ
Ansell USD 274.8M 7.6M 2025-12
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 78.34M 109K 2025-12
Baxter International USD 761M 53M 2025-12
Cochlear AUD 449.4M 214.45M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
CSL USD 1.23B 498M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Fisher Paykel Healthcare NZD 285.5M 11.6M 2025-12
Globus Medical USD 318.48M 4.88M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
Idexx Laboratories USD 275.68M 10.58M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 687.1M 113.8M 2025-12
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Philips EUR 1.31B 127M 2025-12
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 278.4M 19.2M 2025-12
Sigma Healthcare AUD 134.77M 9.73M 2024-12
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Steris USD 352.3M 2.6M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Thermo Fisher Scientific USD 1.98B 182M 2025-12